Friday, October 31, 2025 2:49:28 PM
"the only effective treatment for GBM for the WHOLE world"
Until DC-Vax is actually approved elsewhere, the WHOLE world will have to travel to the UK and stay there to get treated, unless and until other RAs also approve. It's just possible that it could go much more quickly than I believe is possible, but I'm not holding my breath, and when NW announces progress with that, then I'll start to believe it's coming. I think that Sawston just might be running at max capacity by the end of the first year of commercial production, but more likely than not, it will take that year before it reaches monthly capacity. We'll see, and I'll be very glad just to reach max capacity for artisan by the end of year 1. A wish is not a plan, so don't dream up fairy tales to get yourself worked up.
Until DC-Vax is actually approved elsewhere, the WHOLE world will have to travel to the UK and stay there to get treated, unless and until other RAs also approve. It's just possible that it could go much more quickly than I believe is possible, but I'm not holding my breath, and when NW announces progress with that, then I'll start to believe it's coming. I think that Sawston just might be running at max capacity by the end of the first year of commercial production, but more likely than not, it will take that year before it reaches monthly capacity. We'll see, and I'll be very glad just to reach max capacity for artisan by the end of year 1. A wish is not a plan, so don't dream up fairy tales to get yourself worked up.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
